Document is current

Article History

Received: 17 January 2021

Accepted: 4 August 2021

First Online: 13 September 2021

Competing interests

: Georg Ertl has received grants and honoraria from Bayer, Vifor, Novartis, and Boehringer Ingelheim. Kornelia Kotseva reports personal fees from Amgen Europe (consultancy fee) and personal fees from AstraZeneca (advisory board), outside the submitted work. Caroline Morbach reports a research cooperation with the University of Würzburg and Tomtec Imaging Systems funded by a research grant from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, Germany, speakers honorarium from Amgen and Tomtec, a travel grant from Orion Pharma and Alnylam, and participation in Advisory and Patient Eligibility Boards sponsored by AKCEA, Alnylam, and EBR Systems, outside the submitted work. Götz Gelbrich reports grants from the Bavarian Sate Ministry of Economic Affairs (automatic measurement in echocardiography project) and Deutsche Forschungsgemeinschaft (FIND-AF II trial), outside the submitted work. Peter Heuschmann reports grants from German Ministry of Research and Education, German Research Foundation, European Union, Federal Joint Committee (G-BA) within the Innovationfond, Charité–Universitätsmedizin Berlin, Berlin Chamber of Physicians, German Parkinson Society, University Hospital Würzburg, Robert Koch Institute, German Heart Foundation, University Göttingen (within FIND-AF randomised, supported by an unrestricted research grant to the University Göttingen from Boehringer-Ingelheim), University Hospital Heidelberg (within RASUNOA-prime, supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer, BMS, Boehringer-Ingelheim, Daiichi Sankyo), grants from Charité–Universitätsmedizin Berlin (within Mondafis, supported by an unrestricted research grant to the Charité from Bayer), outside the submitted work. Stefan Störk reports grants from Bundesministerium für Bildung und Forschung, other from Boston Scientific, other from Bayer, grants and other from Novartis, other from Boehringer Ingelheim, other from Vifor Pharma, other from Philips, grants from European Union, grants from Deutsche Herzstiftung, outside the submitted work. The remaining authors declare that they have no competing interests.